Firms with manufacturing base in Brazil gain edge in state-backed R&D programme
This article was originally published in Clinica
Executive Summary
Medtech and pharma firms with manufacturing facilities in Brazil are being given priority in competitions for state-cofunded R&D, under changes to the “production development partnership” (PDP) programme. This and other selection criteria and rules have been enacted by the health ministry through the bill Portaria 837, of 18 April 2012.